Nasdaq
ACRV
Acrivon Therapeutics, Inc.
- Health Care
- Listed 2022
- 1 day
- +3.0%
- 1 month
- −9.1%
- 1 year
- +31.0%
$1.69 · Mkt cap $72.3M
At the 6 Aug 2026 close
Nasdaq
Acrivon Therapeutics, Inc.
$1.69 · Mkt cap $72.3M
At the 6 Aug 2026 close
Acrivon Therapeutics, Inc. trades under the ticker ACRV on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2022. Its market capitalisation is $72.3M. The last closing price was $1.69, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +31.0%, and −9.1% over the past month. Returns are price returns and exclude dividends.
This page exists because ACRV is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.